ARCHIVES

In Brief: Oldham To Head Biological Response Modifiers Program; Walter, Namovicz Named Acting Heads

This article is from The Cancer Letter archive.

Vol. 06 No. 32 | August 8, 1980

Download PDF Visit The Full Archive

Related Articles

Phase III Trial of ThermoDox Fails to Meet Primary Endpoint

February 22, 2013

Alan Rabson Outlasts Them All, Even His Bosses, As DCBD Chief

January 15, 1982

Obama Signs Bill Giving FDA Authority Over Tobacco Products

June 26, 2009

FDA Selects 23 Survivors To Review Drug Applications.

June 15, 2001

Trastuzumab Showed Improved Survival In Stage IV Breast Cancer with CNS Metastases

August 26, 2011

In Brief: DCCR Advisory Committee Meeting Rescheduled; Durant To Head Cooperative Group Chairman

June 29, 1979